|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: UNILAB CORP /DE/, 10-Q, EX-99, 2000-10-31 |
Next: ALEXION PHARMACEUTICALS INC, 424B5, 2000-10-31 |
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000899714
<NAME> Unilab Corporation
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> Dec-31-2000
<PERIOD-END> Sep-30-2000
<CASH> 12,248
<SECURITIES> 0
<RECEIVABLES> 88,869
<ALLOWANCES> (26,485)
<INVENTORY> 3,831
<CURRENT-ASSETS> 80,434
<PP&E> 52,645
<DEPRECIATION> (39,566)
<TOTAL-ASSETS> 209,889
<CURRENT-LIABILITIES> 49,597
<BONDS> 151,336
0
0
<COMMON> 259
<OTHER-SE> (151,579)
<TOTAL-LIABILITY-AND-EQUITY> 209,889
<SALES> 251,156
<TOTAL-REVENUES> 251,156
<CGS> 0
<TOTAL-COSTS> 151,539
<OTHER-EXPENSES> 42,253
<LOSS-PROVISION> 18,242
<INTEREST-EXPENSE> 28,116
<INCOME-PRETAX> 11,006
<INCOME-TAX> 4,622
<INCOME-CONTINUING> 6,384
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 6,384
<EPS-BASIC> 0
<EPS-DILUTED> 0
</TABLE>
|
|